Medicine and Dentistry
Low Drug Dose
100%
Arsenic
100%
Bone Marrow
80%
Protein P53
60%
Ibritumomab Tiuxetan
60%
Therapeutic Procedure
30%
Tissues
30%
Tumor Suppressor Protein
30%
Chemotherapy
20%
Toxicity
20%
Radioimmunotherapy
20%
Bone Marrow Cell
20%
Neoplasm
10%
Cell Population
10%
Morphology
10%
Radiation Therapy
10%
Fluorouracil
10%
Cancer Cell
10%
Xenograft
10%
DNA Damage
10%
Tumor Progression
10%
Injury
10%
Leukemia
10%
Cancer Inhibition
10%
DNA Nucleotidylexotransferase
10%
TUNEL Assay
10%
DNA Damage Response
10%
Development
10%
Myelodysplastic Syndrome
10%
Haematoxylin
10%
Eosin
10%
Lymphoma Cell
10%
Cells
10%
Observation
10%
Immunology and Microbiology
Low Drug Dose
100%
P53
60%
Ibritumomab Tiuxetan
60%
Tissues
40%
Mouse
30%
Cell Population
10%
DNA Damage
10%
DNA Damage Response
10%
Cancer Cell
10%
Morphology
10%
Animal Experiment
10%
Xenograft
10%
X Ray
10%
Electric Potential
10%
Lymphoma Cell
10%
Staining
10%
Growth
10%
Development
10%
Cells
10%
Experiment
10%
Time
10%
Dose
10%
Pharmacology, Toxicology and Pharmaceutical Science
Arsenic
100%
Protein P53
60%
Ibritumomab Tiuxetan
60%
Mouse
30%
Toxicity
20%
X-Ray
20%
Neoplasm
10%
Fluorouracil
10%
DNA
10%
Leukemia
10%
DNA Nucleotidylexotransferase
10%
Tumor Growth
10%
Myelodysplastic Syndrome
10%
Cancer Inhibition
10%
Injury
10%
Hematoxylin
10%
Eosin
10%
Neuroscience
P53
60%
Ibritumomab Tiuxetan
60%
DNA
10%
Radiation Therapy
10%
DNA Damage
10%
DNA Damage Response
10%
Chemotherapy
10%
Fluorouracil
10%
Hematoxylin
10%
Suppression
10%
Biochemistry, Genetics and Molecular Biology